Curran D, van Oorschot D, Buck PO, Patterson BJ, Lee BY, Yawn BP, Hicks KA, Carrico J. Cost-effectiveness analysis of Shingrix for vaccinating US adults against herpes zoster. Presented at the ACIP Herpes Zoster Working Group; May 2017. Atlanta, GA.
Hicks KA, Bowers LD. A model for developing athlete testing strategies based on the costs and benefits of doping. Presented at the 14th Annual USADA Symposium on Anti-Doping Science; October 4, 2015. Leesburg, VA.
Sansom S, Lasry A, Hicks KA. The optimal allocation of HIV prevention dollars. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.
Hicks KA. Making use of cost-effectiveness analysis in the community planning process: methods and tools. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.
Hicks KA, Honeycutt AA. Comparing children's immunization interventions: AFIX, RR, and WIC. Presented at the National Immunization Program Tuesday Seminar; January 2006.